ArticleWorld journal of urology2016

Clinical outcomes and nadir prostate-specific antigen (PSA) according to initial PSA levels in primary androgen deprivation therapy for metastatic prostate cancer.

Yasuhide Kitagawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.